Suchen Sie in klinischen Studien nach: Antilymphocyte Serum

Bedingungen: New-onset Type 1 Diabetes Mellitus

Bedingungen: Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted

Bedingungen: Diabetes Mellitus, Type 1

Bedingungen: Myelodysplastic Syndrome

Bedingungen: Graft vs Host Disease

Bedingungen: Breast Cancer

Bedingungen: Leukemia, GVHD, ATG, Transplantation

Bedingungen: Acute Leukemia; Myelodysplasia; Chronic Graft-versus-host-disease

Bedingungen: Multiple Myeloma and Plasma Cell Neoplasm

Bedingungen: Aplastic Anemia

Bedingungen: Aplastic Anemia

Bedingungen: Graft Versus Host Disease

Bedingungen: Myelodysplastic Syndrome

Bedingungen: Graft-vs-host Disease

Bedingungen: Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell Neoplasm

Bedingungen: Myelodysplastic Syndrome (MDS)

Bedingungen: Multiple Myeloma and Plasma Cell Neoplasm

Bedingungen: Kidney Transplant Rejection

Bedingungen: Aplastic Anemia

Bedingungen: Myelodysplastic Syndromes

Bedingungen: Severe Immunodeficiency Diseases

Bedingungen: Hematologic Diseases; Myelodysplastic Syndromes

Bedingungen: Mycoses; Sezary Syndrome; Lymphoma, T-Cell, Cutaneous; Bone Marrow Transplant Failure; Lymphoma, Non-Hodgkin; Cutaneous T-cell Lymphoma

Bedingungen: Myeloproliferative Disorders; Blood Cancer; Myelodysplastic Syndromes

Bedingungen: Acute Myeloid Leukemia; Myelodysplastic Syndrome; Acute Lymphocytic Leukemia; Relapsed/Refractory Chronic Lymphocytic Leukemia; Relapsed/Refractory Non Hodgkin's Lymphoma; Hodgkins Disease; Relapsed Refractory Multiple Myeloma